Plasmodium falciparum Kinetics during Treatment with Antimalarial Drugs in Children

被引：0
|
作者：
A. Sowunmi
A. A. Adedeji
F. A. Fehintola
A. M. J. Oduola
机构：
[1] University of Ibadan,Department of Pharmacology and Therapeutics and Postgraduate Institute for Medical Research and Training
[2] University College Hospital,Clinical Pharmacology Unit
来源：
Clinical Drug Investigation | 2000年 / 20卷
关键词：
Plasmodium Falciparum; Chloroquine; Artemisinin; Antimalarial Drug; Parasite Density;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: To examine the kinetics of the disposition of Plasmodium falciparum during treatment with antimalarial drugs in 565 children presenting with acute, symptomatic, uncomplicated malaria.
引用
收藏
页码：43 / 51
页数：8
相关论文
共 50 条
  • [31] Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in Northern Uganda
    Fukuda, Naoyuki
    Tachibana, Shin-Ichiro
    Ikeda, Mie
    Sakurai-Yatsushiro, Miki
    Balikagala, Betty
    Katuro, Osbert T.
    Yamauchi, Masato
    Emoto, Sakurako
    Hashimoto, Muneaki
    Yatsushiro, Shouki
    Sekihara, Makoto
    Mori, Toshiyuki
    Hirai, Makoto
    Opio, Walter
    Obwoya, Paul S.
    Auma, Mary A.
    Anywar, Denis A.
    Kataoka, Masatoshi
    Palacpac, Nirianne M. Q.
    Odongo-Aginya, Emmanuel, I
    Kimura, Eisaku
    Ogwang, Martin
    Horii, Toshihiro
    Mita, Toshihiro
    PARASITOLOGY INTERNATIONAL, 2021, 81
  • [32] In vitro susceptibility of Plasmodium falciparum isolates from Myanmar to antimalarial drugs
    Wongsrichanalai, C
    Lin, K
    Pang, LW
    Faiz, MA
    Noedl, H
    Wimonwattrawatee, T
    Laoboonchai, A
    Kawamoto, F
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2001, 65 (05): : 450 - 455
  • [33] Transmission of Plasmodium falciparum after treatment with first line antimalarial drugs [MIM-TB-466180]
    Bousema, J.
    Schneider, P.
    Gouagana, L.
    Houben, R.
    Tostmann, A.
    Githure, J.
    Omar, S.
    Sauerwein, R.
    ACTA TROPICA, 2005, 95 : S208 - S209
  • [34] Liver enzymes during and after antimalarial therapy in Nigerian children with uncomplicated Plasmodium falciparum infection
    Olofin, Zacchaeus
    Orimadegun, Adebola
    Falade, Catherine
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 427 - 427
  • [35] Liver enzymes during and after antimalarial therapy in Nigerian children with uncomplicated Plasmodium falciparum infection
    Olofin, Zacchaeus F.
    Orimadegun, Adebola E.
    Falade, Catherine O.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 576 - 576
  • [36] Liver enzymes during and after antimalarial therapy in Nigerian children with uncomplicated Plasmodium falciparum infection
    Olofin, Zacchaeus F.
    Orimadegun, Adebola E.
    Falade, Catherine O.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 446 - 446
  • [37] Antimalarial Drug Targets and Drugs Targeting Dolichol Metabolic Pathway of Plasmodium falciparum
    Qidwai, Tabish
    Priya, Avantika
    Khan, Nihal Ahmad
    Tripathi, Himanshu
    Khan, Feroz
    Darokar, Mahendra Pandurang
    Pal, Anirban
    Bawankule, Dnyneshwar U.
    Shukla, Rakesh Kumar
    Bhakuni, Rajendra Singh
    CURRENT DRUG TARGETS, 2014, 15 (04) : 374 - 409
  • [38] Plasmodium falciparum protein kinase as a potential therapeutic target for antimalarial drugs development
    Mahmud, F.
    Lee, P. C.
    Wahab, Abdul H.
    Mustafa, K. M. F.
    Leow, C. H.
    Azhar, R.
    Lai, N. S.
    TROPICAL BIOMEDICINE, 2020, 37 (03) : 822 - 841
  • [39] A better resolution for integrating methods for monitoring Plasmodium falciparum resistance to antimalarial drugs
    Abdul-Ghani, Rashad
    Al-Maktari, Mohamed T.
    Al-Shibani, Latifa A.
    Allam, Amal F.
    ACTA TROPICA, 2014, 137 : 44 - 57
  • [40] Epidemic of Plasmodium falciparum Malaria Involving Substandard Antimalarial Drugs, Pakistan, 2003
    Leslie, Toby
    Kaur, Harparkash
    Mohammed, Nasir
    Kolaczinski, Kate
    Ord, Rosalynn L.
    Rowland, Mark
    EMERGING INFECTIOUS DISEASES, 2009, 15 (11) : 1753 - 1759
12345